$NTSK

ICONIQ Strategic Partners VIII Holdings, L.P. purchased $3.8M of NTSK

ICONIQ Strategic Partners VIII Holdings, L.P. purchased 306,399 shares of Netskope Inc (NTSK) at an average of $12.29 ($12.26–$12.42, $3.77M total) across 2 trades over 2026-07-10 to 2026-07-13.

Original reporting
SEC EDGAR · ICONIQ Strategic Partners VIII Holdings, L.P.
Published Jul 14, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 14, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NTSK
Bullish
medium confidence
Mentioned
$NTSK
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NTSKBullishLow
01

Why it matters

The newest fact is the disclosed open-market purchase size, price range, and post-transaction holdings, which may slightly influence sentiment but does not change fundamentals on its own.

02

Market read

Traders may monitor for follow-on accumulation or selling patterns, but the filing alone is unlikely to drive a major repricing.

03

What to watch

No 10b5-1 plan is stated, but the article also provides no context on whether this purchase is part of a broader accumulation program or a one-off rebalancing.

Relevance 7/10Novelty 5/10Timing: Filed on 2026-07-14, covering purchases from 2026-07-10 to 2026-07-13.

Background

The article is an SEC Form 4 insider transaction disclosure for Netskope, reported by a 10% owner.

Company-level read

Ticker impact

$NTSKBullishMedium confidence
Context

ICONIQ Strategic Partners VIII Holdings, L.P., a 10% owner, bought 306,399 shares of Netskope in open-market trades totaling about $3.77M.

Expected impact

Likely limited near-term impact; any effect is more sentiment/positioning than a re-rating catalyst.

Evidence & confidence

The filing is a primary Form 4 disclosure, but it does not include new operating guidance, contracts, or regulatory outcomes. The transaction size is moderate relative to typical market-moving events.

Market effects

Limited sector read-through; this is a single-issuer insider/large-holder transaction with no stated business development.

None indicated.

None indicated.

Counterpoint

Large-holder buys can be driven by diversification, liquidity needs, or pre-existing mandates rather than a bullish view on near-term fundamentals.

Key entities

  • Netskope Inc

    Subject of the Form 4 insider transaction disclosure.

  • ICONIQ Strategic Partners VIII Holdings, L.P.

    Reporter of the open-market purchase totaling about $3.77M.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NTSKMed

Why Netskope Stock Crushed it This Week

Netskope (NTSK) shares rose 19% this week, benefiting from improved cybersecurity sentiment and a buy rating from Stephens with a $21 price target. The surge followed AI safety concerns raised by industry leaders, driving demand for cybersecurity stocks.

$NTSKHighAI 8/10

Netskope’s (NTSK) AI Security Push Is Already Paying Off

Netskope (NTSK) reported Q2 revenue of $220.5M, up 27% YoY, and raised its full-year outlook. AI security initiatives are driving growth, with 33% of its pipeline in or entering the proof-of-concept phase. However, the company posted negative free cash flow of $29.8M and expects a full-year free cash flow margin of about 2%.

$NTSKHighAI 8/10

Netskope (NTSK) Q2 2027 Earnings Call Transcript

Netskope (NTSK) reported Q2 2027 earnings with ARR of $899M (27% growth), revenue of $220.5M (29% growth), and raised full-year revenue guidance to $888M-$892M. Key metrics include 114% net retention rate, 1,686 large customers, and 59% platform adoption. Management highlighted AI security opportunities and risks, including faster transition to annual billings.

$NTSKMedAI 8/10

Netskope (NTSK) Stock Rises As ARR Growth Outruns Profit Progress

Netskope (NTSK) stock rose 4.3% to $14.34 after reporting Q2 2027 revenue of $220.5m (up 29% YoY) and ARR of $899m (up 27% YoY). Net loss widened 23% to $110.8m, but adjusted operating margin improved to a 9% loss. Management targets positive free cash flow in Q3. Analysts debate whether growth justifies valuation.

$NTSKMed

BMO raises Netskope stock price target on ARR growth outlook

BMO Capital increased its price target for Netskope (NTSK) to $18.00 from $13.00, citing strong ARR growth and improved performance. The stock, trading at $14.29, has a 26% upside potential. Netskope reported Q2 earnings beating estimates, with revenue of $221M and raised its full-year outlook. Multiple analysts raised their price targets following the results.